Home/Filings/4/0001181431-09-020101
4//SEC Filing

van As Andre MD, PhD 4

Accession 0001181431-09-020101

CIK 0000897075other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 12:22 PM ET

Size

7.3 KB

Accession

0001181431-09-020101

Insider Transaction Report

Form 4
Period: 2009-04-14
van As Andre MD, PhD
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-04-14$6.47/sh+30,000$194,10030,000 total
    Exercise: $6.47Exp: 2019-04-14Common Stock (30,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    410
  • Common Stock

    10,000
Footnotes (2)
  • [F1]The option vests and becomes exercisable at a rate of 1/12th per quarter for a period of 3 years.
  • [F2]These shares are subject to stockholder approval of an increase in the number of authorized shares available for issuance under the Company's 2004 Stock Option Plan.

Issuer

REPROS THERAPEUTICS INC.

CIK 0000897075

Entity typeother

Related Parties

1
  • filerCIK 0001384301

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 12:22 PM ET
Size
7.3 KB